ICM Guidelines Discussion: "Why does antibiotic duration after DAIR for PJI matter?" Part 2

Om avsnittet

In the final episode of this 2-part series, Jessica Seidelman, MD and Johannes Plate, MD, PhD conclude the conversation with Alaina Ritter, MD, Geno Tai, MD, and Sumon Nandi, MD on the topic of antibiotic duration following DAIR in PJI analyzed at The International Consensus Meeting in Istanbul, Turkey, May 2025. Here are the ICM links: DOCUMENTS | ICMORTHO. Thanks to bioMérieux for sponsoring this episode. For more information about their BIOFIRE® Joint Infection (JI) Panel and molecular diagnostics solutions, please visit bioMérieux.com.

FOLLOW us on X @jointapproach or Instagram @jointapproachpodcast for more announcements and content, and reach out to us at [email protected]

Om avsnittet

Fler avsnitt

Candidal PJI: Uncommon and Unforgettable, Part 2

Candidal PJI's: Uncommon and Unforgettable, Part 1

Does the "5-second" Rule Apply to Dropped Medical Objects in the OR?

Bugged and Baffled: A Case with Meredith Schade, Kelan Queenan, and Kevin Perry Part 2

Bugged and Baffled: A Case with Meredith Schade, Kelan Queenan, and Kevin Perry- Part 1

Lysins: A Next Generation Treatment Option for PJI? Part 2

Lysins: A Next Generation Treatment Option for PJI? Part 1

ICM Guidelines Discussion: “Should prolonged antimicrobials be given to patients who have undergone recent reimplantation surgery with all cultures being negative?” Part 2

ICM Guidelines Discussion: “Should prolonged antimicrobials be given to patients who have undergone recent reimplantation surgery with all cultures being negative?” Part 1

ICM Guidelines Discussion: "Is there a role for suppressive antibiotic treatment (SAT) only in patients with PJI?” Part 2